(Q38154210)

29 August 2017

MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition (English)

1 reference

29 August 2017

1 reference

0 references

Qianjun He

1

0 references

author name string

Jianlin Shi

series ordinal

2

1 reference

PubMed ID

24142549

29 August 2017

language of work or name

English

0 references

publication date

20 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

26

1 reference

29 August 2017

3

1 reference

29 August 2017

391-411

1 reference

Mesoporous silica nanoparticles in biomedical applications

29 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The Preparation of Alkyltriinethylaininonium–Kaneinite Complexes and Their Conversion to Microporous Materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A new family of mesoporous molecular sieves prepared with liquid crystal templates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Porous thin films of functionalized mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Synthesis of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Functionalized mesoporous silica materials for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Synthesis of core-shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous materials for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Nanostructured mesoporous silica matrices in nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles: structural design and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Biocompatibility of mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles in medicine--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles: A multifunctional nano therapeutic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Toward the Development of Ionically Controlled Nanoscopic Molecular Gates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Synthesis, characterization, and in vitro pH-controllable drug release from mesoporous silica spheres with switchable gates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Fabrication of PDEAEMA-Coated Mesoporous Silica Nanoparticles and pH-Responsive Controlled Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Fabrication of smart nanocontainers with a mesoporous core and a pH-responsive shell for controlled uptake and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Tunable redox-responsive hybrid nanogated ensembles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multiresponsive supramolecular nanogated ensembles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles for intracellular controlled drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

pH-responsive nutraceutical-mesoporous silica nanoconjugates with enhanced colloidal stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

An operational supramolecular nanovalve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

pH-responsive supramolecular nanovalves based on cucurbit[6]uril pseudorotaxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Enzyme-responsive nanoparticles for drug release and diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Protease-activated drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional envelope-type mesoporous silica nanoparticles for tumor-triggered targeting drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Bioresponsive mesoporous silica nanoparticles for triggered drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Design and Synthesis of Multifunctional Drug Carriers Based on Luminescent Rattle-Type Mesoporous Silica Microspheres with a Thermosensitive Hydrogel as a Controlled Switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Magnetic mesoporous silica microspheres with thermo-sensitive polymer shell for controlled drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Up-conversion cell imaging and pH-induced thermally controlled drug release from NaYF4/Yb3+/Er3+@hydrogel core-shell hybrid microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

pH- and photo-switched release of guest molecules from mesoporous silica supports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Ultrasound, pH, and magnetically responsive crown-ether-coated core/shell nanoparticles as drug encapsulation and release systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Targeting of porous hybrid silica nanoparticles to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Nuclear transport of single molecules: dwell times at the nuclear pore complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The nuclear pore complex: bridging nuclear transport and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Gatekeepers of the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional Gold Nanoparticle−Peptide Complexes for Nuclear Targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

The protease-mediated nucleus shuttles of subnanometer gold quantum dots for real-time monitoring of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A tumor cell-specific nuclear targeting signal within chicken anemia virus VP3/apoptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Hydrophobic core/hydrophilic shell structured mesoporous silica nanospheres: enhanced adsorption of organic compounds from water

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Rattle-structured multifunctional nanotheranostics for synergetic chemo-/radiotherapy and simultaneous magnetic/luminescent dual-mode imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Au-nanoparticle coated mesoporous silica nanocapsule-based multifunctional platform for ultrasound mediated imaging, cytoclasis and tumor ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Gold nanorods@mSiO2 with a smart polymer shell responsive to heat/near-infrared light for chemo-photothermal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional hybrid materials for combined photo and chemotherapy of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctional hollow mesoporous silica nanocages for cancer cell detection and the combined chemotherapy and photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Strategies for the discovery and development of therapies for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Colloidal HPMO nanoparticles: silica-etching chemistry tailoring, topological transformation, and nano-biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Examining the relationship between cancer invasion/metastasis and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Cancer stem cells and drug resistance: the potential of nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of Notch signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Polyvalent Mesoporous Silica Nanoparticle-Aptamer Bioconjugates Target Breast Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Ultrasmall sub-10 nm near-infrared fluorescent mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

Reversible pore-structure evolution in hollow silica nanocapsules: large pores for siRNA delivery and nanoparticle collecting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201303123

21 January 2018

Identifiers

DOI

10.1002/ADMA.201303123

1 reference

29 August 2017

1 reference

PubMed ID

24142549